Use of inhaled iloprost in a case of pulmonary hypertension during pediatric congenital heart surgery

Anesthesiology

Volumn 99, Issue 3, 2003, Pages 743-744

  Müller, Matthias ^a   Scholz, Stefan ^b   Kwapisz, Myron ^b   Akintürk, Hakan ^b   Thul, Josef ^b   Hempelmann, Gunter ^a  

^a UNIVERSITY HOSPITAL GIESSEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANESTHETIC AGENT; ANTIBIOTIC AGENT; DIGOXIN; FENTANYL; HYDROCHLOROTHIAZIDE; ILOPROST; ISOFLURANE; MILRINONE; NEUROMUSCULAR BLOCKING AGENT; NITRIC OXIDE; PANCURONIUM BROMIDE; SPIRONOLACTONE;

ARTERIAL OXYGEN SATURATION; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SURGERY; CASE REPORT; CONGENITAL HEART DISEASE; FEMALE; HEART ATRIUM SEPTUM DEFECT; HEART RATE; HEART VENTRICLE SEPTUM DEFECT; HEMODYNAMIC PARAMETERS; HUMAN; INFANT; INTRAOPERATIVE PERIOD; LUNG ARTERY PRESSURE; PEDIATRIC ANESTHESIA; PEDIATRIC SURGERY; PRIORITY JOURNAL; PULMONARY HYPERTENSION; TREATMENT OUTCOME;

ADMINISTRATION, INHALATION; BLOOD PRESSURE; CARDIAC SURGICAL PROCEDURES; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HEART RATE; HEART SEPTAL DEFECTS; HUMANS; HYPERTENSION, PULMONARY; ILOPROST; INTRAOPERATIVE COMPLICATIONS; OXYGEN; VASODILATOR AGENTS;

EID: 0042324884     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200309000-00032     Document Type: Article

References (11)

1. Celermajer DS, Cullen S, Deanfield JE: Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation 1993; 87:440-6
2. Wessel DL, Adatia I, Giglia TM, Thompson JE, Kulik TJ: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 1993; 88:2128-38
3. Schulze-Neick I, Li J, Penny DJ, Redington AN: Pulmonary vascular resistance after cardiopulmonary bypass in infants: Effect on postoperative recovery. J Thorac Cardiovasc Surg 2001; 121:1033-9
4. Habler O, Kleen M, Takenaka S, Leiderer R, Pusch R, Welte M, Zwissler B, Messmer K: Eight hours' inhalation of prostacyclin (PGI2) in healthy lambs: Effects on tracheal, bronchial, and alveolar morphology. Intensive Care Med 1996; 22:1232-8
5. Habler O, Kleen M, Zwissler B, Pusch R, Welte M, Vogelmeier C, Kempter B, Krombach F, Messmer K: Inhalation of prostacyclin (PGI2) for 8 hours does not produce signs of acute pulmonary toxicity in healthy lambs. Intensive Care Med 1996; 22:426-33
6. Rimensberger PC, Spahr-Schopfer I, Berner M, Jaeggi E, Kalangos A, Friedli B, Beghetti M: Inhaled nitric oxide versus aerosolized iloprost in secondary pulmonary hypertension in children with congenital heart disease: Vasodilator capacity and cellular mechanisms. Circulation 2001; 103:544-8
7. Theodoraki K, Rellia P, Thanopouos A, Tsourelis L, Zarkalis D, Sfyrakis P, Antoniou T: Inhaled iloprost controls pulmonary hypertension after cardiopulmonary bypass. Can J Anesth 2002; 49:963-7
8. Hoeper MM, Olschewski H, Ghofrani HA, Wilkens H, Winkler J, Borst MM, Niedermeyer J, Fabel H, Seeger W: A comparison of the acute hemodynamic effects of inhaled nitric oxide and acrosolized iloprost in primary pulmonary hypertension. German PPH study group. J Am Coll Cardiol 2000; 35:176-82
9. Atz AM, Wessel DL: Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol 1997; 21:441-55
10. Dellinger RP, Zimmerman JL, Taylor RW, Straube RC, Hauser DL, Criner GJ, Davis KJ, Hyers TM, Papadakos P: Effects of inhaled nitric oxide in patients with acute respiratory distress syndrome: Results of a randomized phase 11 trial. Inhaled Nitric Oxide in ARDS Study Group. Crit Care Med 1998; 26:15-23
11. Atz AM, Adatia I, Wessel DL: Rebound pulmonary hypertension after inhalation of nitric oxide. Ann Thorac Surg 1996; 62:1759-64